Introduction: Due to the ability to mimic in vivo cellular microenvironments, the development of multicell culture systems has received increasing interest for use as research models and serving as platforms for drug evaluation. Methods: In this study, we developed a perfused microfluidic system to resemble the in vivo intercellular environment and applied it to study the differentiation from neural stem cells into neurons. Results: As determined by immunofluorescence chemistry and quantitative real-time PCR, the neural stem cells grown in this microfluidic system showed an elevated differentiation rate toward the formation of neurons as determined by the increased level of βIII-tubulin production, which is 4 times higher than that of culturing neural stem cells only. Conclusion: These results revealed that some factors secreted into the intercellular microenvironment by adult neuron cells can stimulate the differentiation of neural stem cells, pointing to the importance of developing multicellular culture systems such as the perfused microfluidic system we report here to better resemble the in vivo situation.

Keywords:
Perfusion, Microfluidic, Neural stem cells, Neurons
1.
Chapman, L.A., R.J. Shipley, J.P. Whiteley, M.J. Ellis, H.M. Byrne, S.L. Waters (2014) Optimising cell aggregate expansion in a perfused hollow fibre bioreactor via mathematical modelling. PloS One 9: e105813.
2.
Chen, Q., J. Wu, Q. Zhuang, X. Lin, J. Zhang, J.M. Lin (2013) Microfluidic isolation of highly pure embryonic stem cells using feeder-separated co-culture system. Sci Rep 3: 2433.
3.
Chou, C.-H., J.D. Sinden, P.-O. Couraud, M. Modo (2014) In vitro modeling of the neurovascular environment by coculturing adult human brain endothelial cells with human neural stem cells. PLoS One 9: e106346.
4.
Emsley, J.G., B.D. Mitchell, G. Kempermann, J.D. Macklis (2005) Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog Neurobiol 75: 321–341.
5.
Goers, L., P. Freemont, K.M. Polizzi (2014) Co-culture systems and technologies: taking synthetic biology to the next level. J R Soc Interface 11: 20140065.
6.
Gómez, R.M., M.Y. Sánchez, M. Portela-Lomba, K. Ghotme, G.E. Barreto, J. Sierra, M.T. Moreno-Flores (2018) Cell therapy for spinal cord injury with olfactory ensheathing glia cells (OECs). Glia 66: 1267–1301.
7.
Hullmann, M., C. Albrecht, D. van Berlo, M.E. Gerlofs-Nijland, T. Wahle, A.W. Boots, J. Krutmann, F.R. Cassee, T.A. Bayer, R.P.F. Schins (2017) Diesel engine exhaust accelerates plaque formation in a mouse model of Alzheimer’s disease. Part Fibre Toxicol 14: 35.
8.
Li, Z., Z. Cui (2014) Three-dimensional perfused cell culture. Biotechnol Adv 32: 243–254.
9.
Liu, S., T. Schackel, N. Weidner, R. Puttagunta (2017) Biomaterial-supported cell transplantation treatments for spinal cord injury: challenges and perspectives. Front Cell Neurosci 11: 430.
10.
Liu, Y., L. Wang, Z. Long, L. Zeng, Y. Wu (2012) Protoplasmic astrocytes enhance the ability of neural stem cells to differentiate into neurons in vitro. PLoS One 7: e38243.
11.
McRae, M., L.M. LaFratta, B.M. Nguyen, J.J. Paris, K.F. Hauser, D.E. Conway (2018) Characterization of cell-cell junction changes associated with the formation of a strong endothelial barrier. Tissue Barriers 6: e1405774.
12.
Nguyen, H.X., M.J. Hooshmand, H. Saiwai, J. Maddox, A. Salehi, A. Lakatos, R.A. Nishi, D. Salazar, N. Uchida, A.J. Anderson (2017) Systemic neutrophil depletion modulates the migration and fate of transplanted human neural stem cells to rescue functional repair. J Neurosci 37: 9269–9287.
13.
Nuryyev, R.L., T.L. Uhlendorf, W. Tierney, S. Zatikyan, O. Kopyov, A. Kopyov, J. Ochoa, W.V. Trigt, C.S. Malone, R.W. Cohen (2017) Transplantation of human neural progenitor cells reveals structural and functional improvements in the spastic Han-Wistar rat model of ataxia. Cell Transplant 26: 1811–1821.
14.
Obayashi, S., H. Tabunoki, S.U. Kim, J. Satoh (2009) Gene expression profiling of human neural progenitor cells following the serum-induced astrocyte differentiation. Cell Mol Neurobiol 29: 423–438.
15.
Okamoto, H., K. Kawamura, T. Nishiyama, T. Fujii, K. Furukawa (2013) Development of a fixed-bed anammox reactor with high treatment potential. Biodegradation 24: 99–110.
16.
Parrish, J., K.S. Lim, K. Baer, G.J. Hooper, T.B.F. Woodfield (2018) A 96-well microplate bioreactor platform supporting individual dual perfusion and high-throughput assessment of simple or biofabricated 3D tissue models. Lab Chip 18: 2757–2775.
17.
Patnaik, R., A. Sharma, S.D. Skaper, D.F. Muresanu, J.V. Lafuente, R.J. Castellani, A. Nozari, H.S. Sharma (2018) Histamine H3 inverse agonist BF 2649 or antagonist with partial H4 agonist activity clobenpropit reduces amyloid beta peptide-induced brain pathology in Alzheimer’s disease. Mol Neurobiol 55: 312–321.
18.
Richert, L., D. Binda, G. Hamilton, C. Viollon-Abadie, E. Alexandre, D. Bigot-Lasserre, R. Bars, P. Coassolo, E. LeCluyse (2002) Evaluation of the effect of culture configuration on morphology, survival time, antioxidant status and metabolic capacities of cultured rat hepatocytes. Toxicol In Vitro 16: 89–99.
19.
Shi, M., D. Majumdar, Y. Gao, B.M. Brewer, C.R. Goodwin, J.A. McLean, D. Li, D.J. Webb (2013) Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts. Lab Chip 13: 3008.
20.
Sorce, S., R. Stocker, T. Seredenina, R. Holmdahl, A. Aguzzi, A. Chio, A. Depaulis, F. Heitz, P. Olofsson, T. Olsson, V. Duveau, D. Sanoudou, S. Skosgater, A. Vlahou, D. Wasquel, K.H. Krause, V. Jaquet (2017) NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: what is the evidence? Free Radic Biol Med 112: 387–396.
21.
Vormann, M.K., L. Gijzen, S. Hutter, L. Boot, A. Nicolas, A. van den Heuvel, J. Vriend, C.P. Ng, T.T.G. Nieskens, V. van Duinen, B. de Wagenaar, R. Masereeuw, L. Suter-Dick, S.J. Trietsch, M. Wilmer, J. Joore, P. Vulto, H.L. Lanz (2018) Nephrotoxicity and kidney transport assessment on 3D perfused proximal tubules. AAPS J 20: 90.
22.
Wan, X., Z. Li, H. Ye, Z. Cui (2016) Three-dimensional perfused tumour spheroid model for anti-cancer drug screening. Biotechnol Lett 38: 1389–1395.
23.
Wu, Y., J. Sun, J. George, H. Ye, Z. Cui, Z. Li, Q. Liu, Y. Zhang, D. Ge, Y. Liu (2016) Study of neuroprotective function of Ginkgo biloba extract (EGb761) derived-flavonoid monomers using a three-dimensional stem cell-derived neural model. Biotechnol Prog 32: 735–744.
24.
Yamada, K.M., E. Cukierman (2007) Modeling tissue morphogenesis and cancer in 3D. Cell 130: 601–610.
25.
Yu, Z., Y. Men, P. Dong (2017) Schwann cells promote the capability of neural stem cells to differentiate into neurons and secret neurotrophic factors. Exp Ther Med 13: 2029–2035.
26.
Zanforlin, E., G. Zagotto, G. Ribaudo (2017) The medicinal chemistry of natural and semi-synthetic compounds against Parkinson’s and Huntington’s diseases. ACS Chem Neurosci 8: 2356–2368.
27.
Zhao, Y., L. Cong, W.J. Lukiw (2017) Lipopolysaccharide (LPS) accumulates in neocortical neurons of Alzheimer’s disease (AD) brain and impairs transcription in human neuronal-glial primary co-cultures. Front Aging Neurosci 9: 407.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.